TRED

Mumbai, India Founded: 2021 • Age: 5 yrs
Designs high-quality insoles for foot support, pain relief, and sports performance.

About TRED

TRED is a company based in Mumbai (India) founded in 2021. It operates as a D2C and B2C. The company has 6 employees. TRED offers products and services including Glyde Insoles, Reinforce Insoles, and ICE Insoles. TRED operates in a competitive market with competitors including Frido, Your Foot Doctor and Hykle, among others.

  • Headquarter Mumbai, India
  • Employees 6
  • Sectors
    Healthcare
    Consumer
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website tredinsoles.com
  • Social Facebook Instagram
  • Legal Name Kan Innovations Private Limited
  • Date of Incorporation 09 Apr, 2019
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹2.44 Cr

    FY 2024 · +13% YoY

  • Net Loss
    -₹1.22 Cr

    FY 2024 · -50% margin

  • EBITDA
    -₹74.7 Lakh

    FY 2024 · -31% margin

  • Employee Count
    6

Products & Services of TRED

TRED offers a comprehensive portfolio of products and services, including Glyde Insoles, Reinforce Insoles, and ICE Insoles.

Glyde Insoles
Orthopedic Insole

Provides support and stability for daily foot comfort.

Reinforce Insoles
Orthopedic Insole

Offers stability for flat feet and reduces fatigue.

ICE Insoles
Orthopedic Insole

Relieves heel pain and enhances mobility for users.

Board of directors of Kan Innovations Private Limited (TRED)

Kan Innovations Private Limited is the primary company behind TRED. The board of Kan Innovations Private Limited currently have 2 directors; the longest-serving is Riday Pradeep Nakhate, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Riday Pradeep Nakhate
DIN 08416693
Director09 Apr 20197 yrs 6 moKan Innovations Private Limited
Bharat Kalyanji Gala
DIN 08416694
Director09 Apr 20197 yrs 6 moKan Innovations Private Limited

Financials of TRED

Figures of Kan Innovations Private Limited, the primary company behind TRED, for FY 2024. Revenue was ₹2.44 Cr (+13% year on year). Net loss was -₹1.22 Cr (-50% margin). EBITDA was -₹74.7 Lakh (-31% margin). Revenue has grown at a compounded annual rate of +107% over three years.

  • ₹2.44 CrRevenue · FY 2024 · +13% YoY
  • -₹1.22 CrNet loss · -50% margin
  • -₹74.7 LakhEBITDA · -31% margin
  • ₹10 LakhPaid-up capital
  • 6Employees (provident fund records)
  • +107%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Kan Innovations Private Limited are on its company page.

Premium access

Detailed financial statements for TRED

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of TRED

TRED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Frido, Your Foot Doctor and Hykle, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
myfrido.com2015Pune, India$23.24M271
Ergonomic products for pain relief and posture support are provided.
yourfootdoctor.in2020Mumbai, India$53,491–
Multi-category insoles for men and women are provided online.
hykle.com2015Sofia, Bulgaria––
Offers insoles, compression socks, and accessories for enhanced support in daily activities.
Premium access

Detailed competitors of TRED

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of TRED

The website of TRED (tredinsoles.com) receives about 680.7K visits a month.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with TRED. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for TRED

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to TRED

10 companies that operate in the same segment as TRED (Pain Management), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Developer of therapeutics for pain relief and inflammatory diseases
2004New York, New York, United StatesUSD 51 MUSD 4.33 M79
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed.
2007Philadelphia, Pennsylvania, United StatesUSD 203 MUSD 3.13 M35
Therapeutics for migraine treatment are developed using nasal delivery.
2016San Francisco, California, United StatesUSD 74.13 M–24
Pain treatment products are developed through reformulation technologies.
2007Herzliya, Central District, IsraelUSD 12 MUSD 17 K6
Drug delivery systems for CNS disorders and pain are developed.
2006Emeryville, California, United StatesUSD 149.06 M––
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
2010Bloomington, Indiana, United StatesUSD 530 MUSD 91.65 M–
Therapies for pain and addiction treatment are developed.
1977Saint-cloud, FranceUSD 248.09 MUSD 167.87 M–
Novel drug products for chronic pain treatment are developed.
2007Blue Bell, Pennsylvania, United StatesUSD 12.96 M–17
Abuse-deterrent extended-release therapeutics for chronic pain are developed.
2002Canton, Ohio, United StatesUSD 103 MUSD 780.57 M357
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about TRED

TRED was founded in 2021.

TRED is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

TRED has 6 employees.

The primary company behind TRED, Kan Innovations Private Limited, reported revenue of β‚Ή2.44 Cr for FY 2024, up 13% year on year.

TRED Insoles, created by podiatrists and engineers, provides prefabricated solutions for various foot conditions like flat feet and heel pain. The products enhance stability, reduce fatigue, and prevent injuries through innovative designs. Based in Mumbai, India, the company sells items such as Glyde and ICE Insoles via an online platform, targeting consumers seeking everyday comfort and health improvements.

TRED's top competitors include Frido, Your Foot Doctor and Hykle.

TRED offers Glyde Insoles, Reinforce Insoles, and ICE Insoles.

TRED operates through Kan Innovations Private Limited.

The legal entities of TRED currently have 2 directors, including Riday Pradeep Nakhate, Bharat Kalyanji Gala.

The website of TRED receives about 681 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available